References
- Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (Adipose Most Abundant Gene Transcript 1). Biochem Biophys Res Commun 1996; 221: 286–9.
- Kishore U, Reid KB. Modular organization of proteins containing C1q-like globular domain. Immunopharmacology 1999; 42: 15–21.
- Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26746–9.
- Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79–83.
- Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595–9.
- Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 2473–6.
- Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7: 941–6.
- Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001; 86: 3815–9.
- Cunningham FG, MacDonald PC, Gant NF, Leveno KJ, Gilstrap LC et al. Williams’ Obstetrics, 20th edn. Norwalk, CT: Appleton & Lange, 1997: 151–90.
- Leturque A, Ferre P, Burnol AF, Kande J, Maulard P, Girard J. Glucose utilization rates and insulin sensitivity in vivo in tissues of virgin and pregnant rats. Diabetes 1986; 35: 172–7.
- Hill DE. Insulin and fetal growth. Prog Clin Biol Res 1976; 10: 127–39.
- Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002; 8: 1288–95.
- Lin CC, Santolaya-Forgas J. Current concepts of fetal growth restriction: part I. Causes, classification, and pathophysiology. Obstet Gynecol 1998; 92: 1044–55.